1. Digital twins in oncology

   • Sebastian Sager

   Guest Editorial Open access 16 February 2023 Pages: 5475 - 5477

2. Epirubicin, cisplatin plus ifosfamide versus standard chemotherapeutic regimens for advanced/unresectable primary thoracic sarcomas

   • Jeronimo Rafael Rodriguez-Cid
   • Juan Jose Juarez-Vignon Whaley
   • Dan Green-Renner

   Research 04 December 2022 Pages: 5479 - 5491

   

3. Exceptional response to neoadjuvant targeted therapy with the selective RET inhibitor selpercatinib in RET-fusion-associated sarcoma

   • Karin G. Schrenk
   • Wolfram Weschenfelder
   • Andreas Hochhaus

   Research Open access 05 December 2022 Pages: 5493 - 5496

   

4. Immunosuppressive role of SPP1-CD44 in the tumor microenvironment of intrahepatic cholangiocarcinoma assessed by single-cell RNA sequencing

   • Meiling Cheng
   • Guodong Liang
   • Yang Liu

   Research 05 December 2022 Pages: 5497 - 5512

   

5. Orelabrutinib and venetoclax synergistically induce cell death in double-hit lymphoma by interfering with the crosstalk between the PI3K/AKT and p38/MAPK signaling

   • Guangchao Pan
   • Mengya Zhong
   • Jie Zha

   Research 06 December 2022 Pages: 5513 - 5529

   

6. X-linked inhibitor of apoptosis protein is a prognostic marker for a favorable outcome in three identified subsets in resectable adenocarcinoma of the pancreas

   • Karl Knipper
   • Su Ir Lyu
   • the PANCALYZE Study Group

   Research Open access 06 December 2022 Pages: 5531 - 5538

   

7. Interactive webtool for analyzing drug sensitivity and resistance associated with genetic signatures of cancer cell lines

   • Myriam Boeschen
   • Diana Le Duc
   • Susanne Horn

   Research Open access 06 December 2022 Pages: 5539 - 5545

   

8. IL-2/GM-CSF enhances CXCR3 expression in CAR-T cells via the PI3K/AKT and ERK1/2 pathways

   • Liwei Liu
   • Yan Cheng
   • Bo Liu

   Research 06 December 2022 Pages: 5547 - 5557

   

9. Systematic analysis of mistletoe prescriptions in clinical studies

   • Henrike Staupe
   • Judith Buentzel
   • Jutta Huebner

   Research Open access 09 December 2022 Pages: 5559 - 5571

10. Impact of patient nationality on the severity of early side effects after radiotherapy

    • Mümtaz Köksal
    • Romy Streppel
    • Leonard C. Schmeel

    Research Open access 10 December 2022 Pages: 5573 - 5582

    

11. Severe neuromuscular immune-related adverse events of immune checkpoint inhibitors at national cancer center in Korea

    • Jae-Won Hyun
    • Ki Hoon Kim
    • Ho Jin Kim

    Research Open access 10 December 2022 Pages: 5583 - 5589

12. Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study

    • Mara Persano
    • Margherita Rimini
    • Andrea Casadei-Gardini

    Research 13 December 2022 Pages: 5591 - 5602

    

13. Tumor budding as an indicator for lymph node metastasis and prognosis of early gastric cancer

    • Gaoyan Yao
    • Yi Fang
    • Xiaoyun Ding

    Research 13 December 2022 Pages: 5603 - 5616

    

14. KCMF1 regulates autophagy and ion channels’ function in renal cell carcinoma: a future therapeutic target

    • Ashu Singh
    • Saumitra Dey Choudhury
    • Alpana Sharma

    Research 14 December 2022 Pages: 5617 - 5626

    

15. The role of systemic inflammatory response index (SIRI) and tumor-infiltrating lymphocytes (TILs) in the prognosis of patients with laryngeal squamous cell carcinoma

    • Tian Wang
    • Duo Zhang
    • Lei Tao

    Research 15 December 2022 Pages: 5627 - 5636

    

16. Impact of physical activity on postural stability and coordination in children with posterior fossa tumor: randomized control phase III trial

    • Mahmoud Usama
    • Faten Abdelaziem
    • Wael Zekri

    Research Open access 16 December 2022 Pages: 5637 - 5644

    

17. Combinational expression of tumor testis antigens NY-ESO-1, MAGE-A3, and MAGE-A4 predicts response to immunotherapy in mucosal melanoma patients

    • Sandra N. Freiberger
    • David Holzmann
    • Niels J. Rupp

    Research Open access 17 December 2022 Pages: 5645 - 5653

    

18. Psychosocial distress in young adults surviving hematological malignancies: a pilot study

    • Andreas Wittwer
    • Kristin Sponholz
    • Inken Hilgendorf

    Research Open access 17 December 2022 Pages: 5655 - 5663

    

19. Breast cancer therapy in women under 35 years and between 50 and 69 years: influence of the observation period

    • J. Schreiber
    • A. Ignatov
    • H. Eggemann

    Research 20 December 2022 Pages: 5665 - 5676

20. Biomarker concordance between primary colorectal cancer and ovarian metastases: a Dutch cohort study

    • Richard van der Meer
    • Judith W. M. Jeuken
    • Rudi M. H. Roumen

    Research 21 December 2022 Pages: 5677 - 5685

    

21. Endothelin-3 is epigenetically silenced in endometrioid endometrial cancer

    • Nikola Zmarzły
    • Szymon Januszyk
    • Dariusz Boroń

    Research Open access 21 December 2022 Pages: 5687 - 5696

    

22. Correlations between antimicrobial peptides and spectrophotometric skin color parameters in patients with basal cell carcinoma

    • Marta Fijałkowska
    • Mateusz Koziej
    • Aneta Sitek

    Research Open access 21 December 2022 Pages: 5697 - 5704

    

23. Monalizumab efficacy correlates with HLA-E surface expression and NK cell activity in head and neck squamous carcinoma cell lines

    • Jeongjae Lee
    • Bhumsuk Keam
    • Dae Seog Heo

    Research 22 December 2022 Pages: 5705 - 5715

    

24. The antitumor effect of the novel agent MCL/ACT001 in pancreatic ductal adenocarcinoma

    • Juan Yang
    • Yin Li
    • Chenggang Li

    Research 22 December 2022 Pages: 5717 - 5728

    

25. High-dose chemotherapy and autologous stem cell transplantation in primary lymphomatoid granulomatosis of the central nervous system

    • Verena Nilius-Eliliwi
    • Hannes Treiber
    • Roland Schroers

    Research Open access 24 December 2022 Pages: 5729 - 5732

26. The usefulness of a three-protein signature blood assay (Mastocheck®) for follow-up after breast cancer surgery

    • Yumi Kim
    • Hong-Kyu Kim
    • Dong-Young Noh

    Research Open access 24 December 2022 Pages: 5733 - 5741

    

27. A single-institution retrospective analysis of intraoperative radiation boost during breast-conservation treatment for breast cancer

    • Franka Hochhertz
    • Peter Hass
    • Ahmed Gawish

    Research Open access 25 December 2022 Pages: 5743 - 5749

    

28. The basement membrane-related gene signature is associated with immunity and predicts survival accurately in hepatocellular carcinoma

    • Yu Zhao
    • Zhenjie Yin
    • Hongbin Chen

    Research 27 December 2022 Pages: 5751 - 5760

    

29. CACYBP knockdown inhibits progression of prostate cancer via p53

    • Qiang Li
    • Zhili Liu
    • Kan Zhang

    Research Open access 28 December 2022 Pages: 5761 - 5772

    

30. DOAC in the treatment of cancer-associated venous thromboembolism: a retrospective cohort study beyond the guidelines

    • Mattia Cominacini
    • Silvia Suardi
    • Luca Dalle Carbonare

    Research Open access 28 December 2022 Pages: 5773 - 5779

    

31. Clinicopathological features of endoscopically treated early gastric cancer with lymphovascular infiltration

    • Koji Takano
    • Keiichi Ashikari
    • Takuma Higurashi

    Research 30 December 2022 Pages: 5781 - 5790

    

32. The debatable role of immune checkpoint blockade therapy in lung adenocarcinoma-oriented liver metastatic malignant lesions

    • Dan Qiu
    • Hangtian Xi
    • Jian Zhang

    Research 30 December 2022 Pages: 5791 - 5802

    

33. Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread

    • Dawid Sigorski
    • Wojciech Wesołowski
    • Ewa Iżycka-Świeszewska

    Research Open access 30 December 2022 Pages: 5803 - 5822

    

34. Bacterial metabolite butyrate in modulating sorafenib-targeted microRNAs to curtail its resistance in hepatocellular carcinoma

    • Mukesh Kumar
    • Ramanpreet Kaur
    • Anuradha Chakraborti

    Research 30 December 2022 Pages: 5823 - 5839

    

35. Implementing an immunotherapy toxicity (IOTOX) GI service improves outcomes in patients with immune-mediated diarrhea and colitis

    • Alice Saji
    • Maneera Chopra
    • Anusha Thomas

    Research 31 December 2022 Pages: 5841 - 5852

    

36. Impact of breath-hold technique on incidence of cardiac events in adjuvant left breast cancer irradiation

    • Amr A. Mahmoud
    • Emad A. Sadaka
    • Ahmed Gawish

    Research 31 December 2022 Pages: 5853 - 5859

37. Will repeat resection after initial transurethral en bloc resection benefit patients with high-risk non-muscle-invasive bladder cancer? A propensity score matching analysis

    • Mengqi Zhou
    • Binrui Yang
    • Henglong Hu

    Research 31 December 2022 Pages: 5861 - 5869

    

38. Identification and validation of a PD-L1-related signature from mass spectrometry in gastric cancer

    • Xiancong Chen
    • Deli Mao
    • Changhua Zhang

    Research Open access 02 January 2023 Pages: 5871 - 5884

    

39. Involvement of angiogenesis in cancer-associated acinar-to-ductal metaplasia lesion of pancreatic cancer invasive front

    • Shuang Fei
    • Kenoki Ohuchida
    • Masafumi Nakamura

    Research 02 January 2023 Pages: 5885 - 5899

    

40. Dual-layer spectral detector CT (SDCT) can improve the detection of mixed ground-glass lung nodules

    • Zhenghua Zhang
    • Fang Yin
    • Dan Han

    Research 03 January 2023 Pages: 5901 - 5906

    

41. Bevacizumab biosimilar candidate TAB008 compared to Avastin^® in patients with locally advanced, metastatic EGFR wild-type non-squamous non-small cell lung cancer: a randomized, double-blind, multicenter study

    • S. Lu
    • S. Qin
    • J. He

    Research 03 January 2023 Pages: 5907 - 5914

    

42. Effect of antimicrobial therapy on progression-free survival of immunotherapy and chemo-/immunotherapy in patients with non-small cell lung cancer

    • Mark Uhlenbruch
    • Stefan Krüger

    Research 03 January 2023 Pages: 5915 - 5919

    

43. Suppression of exosomal hsa_circ_0001005 eliminates the Vemurafenib resistance of melanoma

    • Xicheng Wang
    • Qiong Cheng

    Research 04 January 2023 Pages: 5921 - 5936

    

44. Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer

    • Florian Lordick
    • Peter Thuss-Patience
    • Özlem Türeci

    Research Open access 06 January 2023 Pages: 5937 - 5950

    

45. Prognostic value of MR-detected mandibular nerve involvement: potential indication for future individual induction chemotherapy in T4 nasopharyngeal carcinoma

    • Wenjie Huang
    • Shuqi Li
    • Lizhi Liu

    Research Open access 06 January 2023 Pages: 5951 - 5964

    

46. Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy

    • Mümtaz Köksal
    • Laura Kersting
    • Leonard C. Schmeel

    Research Open access 06 January 2023 Pages: 5965 - 5973

    

47. Using a zebrafish xenograft tumor model to compare the efficacy and safety of VEGFR-TKIs

    • Hou Wanting
    • Zhong Jian
    • Cao Dan

    Research 07 January 2023 Pages: 5975 - 5987

    

48. Characteristics, treatment, and outcome of patients with bowel perforation after immune checkpoint inhibitor exposure

    • Antonio Pizuorno Machado
    • Malek Shatila
    • Yinghong Wang

    Research 08 January 2023 Pages: 5989 - 5998

    

49. Establishment of a risk stratification model based on the combination of post-treatment serum squamous cell carcinoma antigen levels and FIGO stage of cervical cancer for treatment and surveillance decision-making

    • Liu Shi
    • Yuxin Liu
    • Xinping Cao

    Research Open access 09 January 2023 Pages: 5999 - 6007

    

50. Working situation and burden of work limitations in sarcoma patients: results from the multi-center prospective PROSa study

    • Sergio Armando Zapata Bonilla
    • Marius Fried
    • Martin Eichler

    Research Open access 10 January 2023 Pages: 6009 - 6021